Our two production workshops, which meets China and EU's GMP standards and equipped with world class integrated BFS system, the automatic liquid mixing and distribution system and the Nikka pinhole inspector, have an annual production capacity of 80,000,000 pcs.
-
-
Inhalation
H1702
Promote the movement of bronchial mucosa cilia to expel sputum. Mainly used to alleviate chronic obstructive pulmonary disease caused by bronchial asthma spasm symptoms, and prevent and cure bronchial asthma.More -
Inhalation
H1701
Promote the movement of bronchial mucosa cilia to expel sputum. Mainly used to alleviate chronic obstructive pulmonary disease caused by bronchial asthma spasm symptoms, and prevent and cure bronchial asthma.More -
Inhalation
H1801
Used in the treatment for severe bronchial asthma (status asthmatics) as well as chronic bronchospasm that does not respond to conventional therapy. Listed in the National Essential Drug List with an board market prospects.More